We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
-13.02%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$38.2B
AUM Growth
-$6.09B
Cap. Flow
+$114M
Cap. Flow %
0.3%
Top 10 Hldgs %
17.6%
Holding
1,625
New
564
Increased
379
Reduced
367
Closed
304

Top Buys

Rank Stock Value
1
EWY icon
iShares MSCI South Korea ETF
EWY
+$612M
2
INTC icon
Intel
INTC
+$419M
3
DIS icon
Walt Disney
DIS
+$322M
4
SBUX icon
Starbucks
SBUX
+$296M
5
C icon
Citigroup
C
+$278M

Sector Composition

Rank Sector Weight
1 Healthcare 21.68%
2 Financials 18.85%
3 Technology 17.88%
4 Consumer Discretionary 11.66%
5 Industrials 6.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TER icon
326
Teradyne
TER
$59.3B
$16.4M 0.04%
+523,900
New +$17.8M
NEE icon
327
NextEra Energy
NEE
$177B
$16.4M 0.04%
+377,848
New +$16.5M
WRK
328
DELISTED
WestRock Company
WRK
$16.3M 0.04%
430,719
+424,619
+6,961% +$18.7M
XLNX
329
DELISTED
Xilinx Inc
XLNX
$16.3M 0.04%
+190,901
New +$16M
SFM icon
330
Sprouts Farmers Market
SFM
$8.01B
$16.2M 0.04%
689,923
-19,611
-3% -$510K
TARO
331
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$16.2M 0.04%
191,208
-15,339
-7% -$1.48M
PVH icon
332
PVH
PVH
$4.04B
$16.1M 0.04%
173,433
+166,119
+2,271% +$19M
CACC icon
333
Credit Acceptance
CACC
$6.08B
$16.1M 0.04%
42,198
-4,950
-10% -$1.99M
ZBH icon
334
Zimmer Biomet
ZBH
$18.4B
$16M 0.04%
159,135
+129,986
+446% +$14.6M
KR icon
335
Kroger
KR
$34.8B
$15.9M 0.04%
+577,751
New +$16.8M
SRCL
336
DELISTED
Stericycle Inc
SRCL
$15.8M 0.04%
+430,028
New +$20.2M
CAE icon
337
CAE Inc. Common Shares
CAE
$8.74B
$15.5M 0.04%
842,317
-88,911
-10% -$1.69M
VEA icon
338
Vanguard FTSE Developed Markets ETF
VEA
$237B
$15.4M 0.04%
416,012
+229,256
+123% +$9.08M
MBFI
339
DELISTED
MB Financial Corp
MBFI
$15.4M 0.04%
387,679
+23,021
+6% +$1M
SPH icon
340
Suburban Propane Partners
SPH
$1.18B
$15.1M 0.04%
781,733
+292,797
+60% +$6.59M
DELL icon
341
Dell
DELL
$293B
$15.1M 0.04%
607,597
-1,149,218
-65% -$31.5M
BIP icon
342
Brookfield Infrastructure Partners
BIP
$18B
$15M 0.04%
+727,410
New +$16.6M
BCS icon
343
Barclays
BCS
$94.1B
$14.9M 0.04%
2,073,035
+30,393
+1% +$245K
UNIT
344
Uniti Group
UNIT
$2.32B
$14.9M 0.04%
959,628
+427,167
+80% +$8.03M
DENN
345
DELISTED
Denny's
DENN
$14.8M 0.04%
914,202
+6,403
+0.7% +$101K
DSGX icon
346
Descartes Systems
DSGX
$6.82B
$14.7M 0.04%
556,949
-286,103
-34% -$8.37M
APH icon
347
Amphenol
APH
$209B
$14.7M 0.04%
+725,028
New +$15.6M
MDU icon
348
MDU Resources
MDU
$4.32B
$14.6M 0.04%
+1,610,807
New +$15.7M
CNMD icon
349
CONMED
CNMD
$1.47B
$14.6M 0.04%
227,002
-1,040
-0.5% -$71.2K
FMX icon
350
Fomento Económico Mexicano
FMX
$41.7B
$14.5M 0.04%
169,064
+61,342
+57% +$5.45M

Similar funds

Arrowstreet Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Arrowstreet Capital held 1,625 positions worth $38.2B, down 14% from $44.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arrowstreet Capital's Q4 2018 filing shows 564 new, 379 increased, 367 reduced and 304 closed positions. Its largest new stake was Starbucks: 4,733,289 shares worth $305M. The largest sale was BP, an estimated $564M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

  • Arrowstreet Capital's largest Q4 2018 buy was Starbucks: 4,733,289 shares worth $305M.
  • Arrowstreet Capital added most to iShares MSCI South Korea ETF in Q4 2018, an estimated $612M increase.
  • Arrowstreet Capital's biggest Q4 2018 reduction was BP, cutting an estimated $564M.
  • Arrowstreet Capital fully exited Royal Dutch Shell PLC ADS Class A in Q4 2018, selling an estimated $455M.
  • Arrowstreet Capital's ten largest holdings make up 18% of its $38.2B portfolio in Q4 2018.
  • Arrowstreet Capital opened 564 new positions and closed 304 in Q4 2018.
  • Arrowstreet Capital's portfolio value fell 14% quarter-over-quarter to $38.2B.

Based on Arrowstreet Capital's 13F filing for Q4 2018, filed 14 Feb 2019.